VCYT (Veracyte) Cyclically Adjusted Book per Share: $10.45 (As of Mar. 2026)


VCYT Veracyte Inc VCYT
75 GF Score
Price $60.38
GF Value $38.11
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Veracyte Cyclically Adjusted Book per Share?

Veracyte VCYT +3.24% 75 Cyclically Adjusted Book per Share is $10.45 as of Mar. 2026. GuruFocus rates VCYT with a GF Score™ of 75/100 and a GF Value™ of $38.11 (Significantly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Veracyte's adjusted book value per share for the three months ended in Mar. 2026 was $16.849. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $10.45 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Veracyte's average Cyclically Adjusted Book Growth Rate was 18.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 22.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Veracyte was 22.30% per year. The lowest was 22.30% per year. And the median was 22.30% per year.

As of today (2026-06-27), Veracyte's current stock price is $60.38. Veracyte's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $10.45. Veracyte's Cyclically Adjusted PB Ratio of today is 5.78.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Veracyte was 7.11. The lowest was 2.56. And the median was 4.02.


Veracyte  (NAS:VCYT) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Veracyte's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=60.38/10.45
=5.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Veracyte was 7.11. The lowest was 2.56. And the median was 4.02.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Veracyte Cyclically Adjusted Book per Share Related Terms


Veracyte Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Veracyte's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veracyte Cyclically Adjusted Book per Share Chart

Veracyte Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 5.41 6.94 8.35 9.89

Veracyte Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.79 9.18 9.57 9.89 10.45

VCYT vs TWST, GRAL, RDNT: Cyclically Adjusted Book per Share Comparison

For the Diagnostics & Research subindustry, Veracyte's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veracyte Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Veracyte's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Veracyte's Cyclically Adjusted PB Ratio falls into.


VCYT
75GF Score
Veracyte Inc VCYT
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veracyte Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Veracyte's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=16.849/330.2130*330.2130
=16.849

Current CPI (Mar. 2026) = 330.2130.

Veracyte Quarterly Data

Book Value per Share CPI Adj_Book
201606 1.211 241.018 1.659
201609 1.074 241.428 1.469
201612 1.765 241.432 2.414
201703 1.575 243.801 2.133
201706 1.412 244.955 1.903
201709 1.260 246.819 1.686
201712 1.088 246.524 1.457
201803 0.874 249.554 1.156
201806 0.749 251.989 0.982
201809 1.959 252.439 2.563
201812 1.952 251.233 2.566
201903 2.018 254.202 2.621
201906 4.647 256.143 5.991
201909 4.732 256.759 6.086
201912 4.825 256.974 6.200
202003 4.608 258.115 5.895
202006 4.483 257.797 5.742
202009 7.312 260.280 9.277
202012 7.238 260.474 9.176
202103 14.490 264.877 18.064
202106 14.394 271.696 17.494
202109 15.586 274.310 18.762
202112 15.417 278.802 18.260
202203 15.192 287.504 17.449
202206 14.871 296.311 16.572
202209 14.610 296.808 16.254
202212 14.942 296.797 16.624
202303 14.938 301.836 16.342
202306 14.905 305.109 16.131
202309 14.440 307.789 15.492
202312 14.251 306.746 15.341
202403 14.637 312.332 15.475
202406 14.757 314.175 15.510
202409 15.176 315.301 15.894
202412 15.120 315.605 15.820
202503 15.260 319.799 15.757
202506 15.535 322.561 15.904
202509 15.913 324.800 16.178
202512 16.502 324.054 16.816
202603 16.849 330.213 16.849

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $10.45 mean?
Veracyte (VCYT) has a Cyclically Adjusted Book per Share of $10.45 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Veracyte and its competitors.
Is Veracyte's Cyclically Adjusted Book per Share too high?
Veracyte's current Cyclically Adjusted Book per Share is $10.45. Overall, Veracyte has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Veracyte's Cyclically Adjusted Book per Share compare to TWST and GRAL?
Veracyte's Cyclically Adjusted Book per Share of $10.45 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Book per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Veracyte and its competitors. Veracyte's current Cyclically Adjusted Book per Share is $10.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veracyte stock overvalued right now?
Based on GuruFocus' analysis, Veracyte (VCYT) is currently considered Significantly Overvalued. The stock's GF Value™ is $38.11, compared to a current price of $60.38 — trading 58.4% above its estimated fair value. The current Cyclically Adjusted Book per Share is $10.45. Veracyte's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Veracyte (VCYT), the current Cyclically Adjusted Book per Share is $10.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Veracyte (VCYT) Overvalued in 2026?

Based on GuruFocus' analysis, Veracyte stock appears to be overvalued. The current stock price of $60.38 is trading 58.4% above its estimated GF Value™ of $38.11. GuruFocus considers Veracyte to be Significantly Overvalued.

Key valuation signals for VCYT:

  • Cyclically Adjusted Book per Share: $10.45
  • GF Value™: $38.11 vs. price of $60.38 (58.4% above fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the VCYT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Veracyte Business Description

Other Exchanges 12V:Germany
Address 6000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
75GF Score

Get the complete analysis for VCYT

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$60.38
Price
$38.11
GF Value